Cargando…

Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research

Detalles Bibliográficos
Autores principales:	Alemayehu, Demissie, Sanchez, Robert J., Cappelleri, Joseph C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2011
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438265/ https://www.ncbi.nlm.nih.gov/pubmed/22074672 http://dx.doi.org/10.18553/jmcp.2011.17.s9-a.S27

Ejemplares similares

Infrastructure Requirements for Secondary Data Sources in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

“Ten Commandments” for Conducting Comparative Effectiveness Research Using “Real-World Data”
por: Willke, Richard J., et al.
Publicado: (2011)

Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
por: Oderda, Gary M., et al.
Publicado: (2011)

Something Old, Something New, Something Borrowed"¦Comparative Effectiveness Research: A Policy Perspective
por: Subedi, Prasun, et al.
Publicado: (2011)

Treatment-Resistant Depression: Managed Care Considerations
por: Tierney, John G.
Publicado: (2007)

Psychosocial and Cultural Contributions to Depression in Women: Considerations for Women Midlife and Beyond
por: Keita, Gwendolyn Puryear
Publicado: (2007)

The Role of Outcomes Research in Defining and Measuring Value in Benefit Decision
por: Nichol, Michael B.
Publicado: (2006)

The Comparative Safety and Effectiveness of TNF-alpha Antagonists
por: Solomon, Daniel H.
Publicado: (2007)

Maximizing the Outcomes in Cancer Patients Receiving
por: Mucenski, John W., et al.
Publicado: (2003)

Improving Cost-Effectiveness of and Outcomes From Drug Therapy in Patients With Atrial Fibrillation in Managed Care: Role of the Pharmacist
por: Johnson, Samuel G.
Publicado: (2009)

Introduction
por: Mullins, C. Daniel, et al.
Publicado: (2011)

Assessing Resource Use in Oncology Patients
por: Semroc, Georgette N., et al.
Publicado: (2003)

Introduction: Targeted Evidenced-Based Colorectal Cancer Therapies: Shifting the Patient Outcome
por: Minkoff, Neil B.
Publicado: (2007)

Developing a Collaborative Study Protocol for Combining Payer-Specific Data and Clinical Trials for CER
por: Sanchez, Robert J., et al.
Publicado: (2011)

Strategies for Optimizing Treatment Outcomes
por: Jones Freeman, Elyce L.
Publicado: (2003)

Identifying Indicators of Outcomes and Implementing Treatment Pathways
por: Huff, Carol Ann, et al.
Publicado: (2012)

Assessment of Disease Activity and Treatment Outcomes in Rheumatoid Arthritis
por: Farheen, Kiran, et al.
Publicado: (2011)

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
por: Scott, Shane J., et al.
Publicado: (2003)

Introduction: Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David
Publicado: (2007)

Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
por: Menzin, Joseph, et al.
Publicado: (2013)

Managing the Intersection of Medical and Pharmacy Benefits
por: McDonald, Robert C.
Publicado: (2008)

A Budget-Impact and Cost-Effectiveness Model for Second-Line Treatment of Major Depression
por: Malone, Daniel C.
Publicado: (2007)

Usefulness of database Studies as Applied to Managed Care
por: Eisenberg, Steven S.
Publicado: (2005)

Implementing CER: What Will It Take?
por: Biskupiak, Joseph E., et al.
Publicado: (2012)

Managing Depressed Patients
por: Arizpe, Michael
Publicado: (2006)

Patient Centric Care Management
por: Chao, Scumarry H.
Publicado: (2006)

Introduction: Medicare Section 1013 and AHRQ's Effective Health Care Program
por: Chao, Schumarry H., et al.
Publicado: (2007)

AHRQ's Effective Health Care Program: Its Impact on Managed Care
por: Fleming, William K.
Publicado: (2007)

The Impact of Residual Cardiovascular Risk in Combination Lipid-Modifying Therapy in the Managed Care Setting
por: Talbert, Robert L.
Publicado: (2008)

Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012)

Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003)

Introduction
por: Lipsy, Robert J.
Publicado: (2003)

Preview Overview
por: Lipsy, Robert J.
Publicado: (2004)

The patient Experience with the mental Health System
por: Wittwer, Sherri D.
Publicado: (2006)

Influencing Patient Adherence to Treatment Guidelines
por: Butterworth, Susan W.
Publicado: (2008)

Can CER Be an Effective Tool for Change in the Development and Assessment of New Drugs and Technologies?
por: Brixner, Diana I., et al.
Publicado: (2012)

Value-Based Benefit Design: Using a Predictive Modeling Approach to Improve Compliance
por: Mahoney, John J.
Publicado: (2008)

Promoting Health and Productivity for Depressed Patients in the Workplace
por: Sullivan, Sean
Publicado: (2005)

Analysis of the Current Care Model of the COPD Patient
por: Minkoff, Neil B.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mihf5sfdutvevjovg43qrhqu08